Mark Stocksdale
Mark Stocksdale

Porter is excited to announce that Mark Stocksdale has joined the team as Chief Information and Technology Officer. Mark is a transformative technology leader and strategist who has successfully delivered innovative technology products across a variety of industries, including logistics, healthcare, pharmaceuticals, and hospitality. With over 25 years of experience, Mark will lead all aspects of Porter's product development, leveraging modern cloud architecture and engineering practices.  

Mark is a leader that excels at translating business strategies into technology products that deliver business outcomes and customer value. Mark's experience in Healthcare, Pharmaceuticals, and Hospitality provides a unique combination of experience, insights, and skills that will help Porter to deliver differentiated experiences that will redefine and simplify the healthcare journey.

Most recently, Mark served as the Chief Enterprise Architect and Vice President, Enterprise Architecture at Marriott International. Mark was responsible for transforming the technology landscape that powered this hospitality organization that serves over 160M members globally.  As a change agent, he defined and implemented cloud-based web and mobile architectures and solutions that transformed the digital and on-property customer experience.

Mark also served as the Head of Global Commercial Architecture at AstraZeneca Pharmaceuticals, where he defined the architecture that supported the deployment of a mobile sales platform that increased engagement through the digitization of content and real-time sample compliance.

Mark holds an MBA from the University of Delaware, Lerner School of Business and Economics, and a Bachelor of Science in Information Systems from the University of Maryland, Baltimore County. In his spare time, Mark enjoys Kayaking, Skiing, Traveling, and spending time with his family. Mark lives with his wife Jodie in Gaithersburg, Md. and often visits his daughter Samantha (24) who resides locally.

Porter's AI-driven platform connects people with everything they need to manage at home during an illness or injury, thus creating a roadmap for comprehensive home care. At Porter, they believe everyone deserves to live their best life. John Criswell, the Founder & CEO of Porter said "Mark shares our purpose and vision at Porter and with his vast background in technology, innovation, supply chain, Ecommerce, and healthcare, Mark's impact is immeasurable and we're all very excited to have him on the Porter team."

For inquiries, call (786) 224-7130 or e-mail [email protected]. Visit helloporter.com for more information on Porter.

Earlier this summer, MTM revealed its planned acquisition of Veyo, the non-emergency medical transportation (NEMT) industry's third largest broker. Today, the organization announced the acquisition has been finalized. The deal closed on Aug. 1, with integration activities set to begin immediately.

Founded in 2015, Veyo leverages data, technology, and their Independent Driver Provider (IDP) model to improve access to care. With combined revenue of approximately $1 billion, MTM and Veyo will jointly serve 15.4 million members in 31 states and the District of Columbia, providing nearly 21 million annual trips.

"With the fusion of the MTM and Veyo organizations, we are excited to deliver more benefits to our NEMT clients and members than ever," said MTM's President and CEO Alaina Macia. "The healthcare industry is innovating at a rapid pace, and the NEMT market is no different. Combining MTM's customer service focus and Veyo's innovative processes and tools, we're primed to deliver an unmatched transportation experience to health plans and their members nationwide."

The organizations plan to seamlessly align their operations to ensure minimal impact on day-to-day services. Veyo clients and their members should expect little to no change in their NEMT program during the initial transition. 

"Our foremost goal is to ensure the integration of Veyo under the MTM umbrella is transparent to our NEMT stakeholders, with improvements and operational alignment in the near future," said Veyo CEO and co-founder Josh Komenda, who will stay on board with MTM in a leadership role. "Veyo and MTM are both companies that were built on cultures of innovation and excellence, and that commitment will be unchanged. We look forward to integrating with MTM to unify our NEMT models, enhance access to healthcare, and improve healthcare outcomes for Medicaid and Medicare members nationwide." 

About MTM 

MTM is the nation's most trusted and qualified partner for healthcare, transportation, and logistics solutions. Since 1995, MTM has managed NEMT for state and county governments, managed care organizations, health systems, and other programs involving transportation for the disabled, underserved, and elderly. Leveraging technology to streamline processes and improve the user experience for all stakeholders, MTM's wide spectrum of services help clients improve health outcomes, promote independence, reduce costs, and increase satisfaction. In 2009, MTM's leadership established MTM Transit, an affiliate that provides direct paratransit and fixed route transit services. MTM and MTM Transit are privately held, woman-owned business enterprises.

About Veyo

Veyo, headquartered in San Diego, California, was established in 2015 as a full-service transportation brokerage designed specifically for healthcare. Veyo has reinvented the patient transportation model by integrating consumer technology with rideshare fleets to decrease costs and increase efficiency. Veyo is delivering dramatically higher levels of reliability, quality, and transparency to customers, partners, and members. 

Press contact: Jessica Williams, 618.772.2349

Mira Ovum Wands
Mira launches Ovum Wand to detect FSH in urine

The FDA has listed Mira's new Mira Ovum Wand as an over-the-counter tool to detect the follicle-stimulating hormone (FSH) in urine. Starting October 2022, the product will be available to U.S. customers. The wands help monitor FSH levels to predict approaching menopause. They can also be used to monitor fertility and find possible causes of reproductive issues for women after 35.

Menopause has been a taboo subject for many generations. The lack of relevant education results in numerous misconceptions about this time in women's lives. Studies show that to this date, one-third of women do not research the topic before they experience menopause. A survey of 1,039 American women ages 40-65 finds that 45% of them didn't know the distinction between perimenopause and menopause. The Mira Ovum Wand can provide information to help understand perimenopause, predict menopause and address the symptoms early. FSH tracking can also help track the effectiveness of hormone replacement therapy to make it more targeted and personalized.

Tracking the follicle-stimulating hormone is essential for women in their 20s, 30s, or 40s because it directly impacts their ability to get pregnant. To predict approaching menopause or track changes in fertility, a person needs to test over several days for two or more cycles. Mira allows users to safely and regularly monitor their FSH levels at home without the need for constant and painful blood tests. And unlike FSH test strips, Mira provides lab-accurate numbers and data points that are saved and analyzed to give users personalized health insights. Users can also choose to share this data with their medical provider. 

 "The Mira Ovum Wand further expands our capabilities in at-home hormone testing. We can now provide accurate lab-like results for LH, E3G, PdG, and FSH. The launch reinforces Mira's goal to support women throughout their lives by helping them understand their hormones at any age, be it puberty, adulthood, or later years. This knowledge grants the ability to make informed fertility decisions and eliminates the dread associated with the word "menopause." So, women can go through this journey with confidence and awareness," says Sylvia Kang, CEO of Mira.

Mira offers a whole line of hormone test wands, including Mira Fertility (luteinizing hormone), Mira Fertility Plus (estrone-3-glucuronide and luteinizing hormone) and Mira Confirm (pregnanediol glucuronide). Like its predecessors, the new Mira Ovum Wand is compatible with the Mira Analyzer. This high-precision testing device uses machine learning to track changing hormone patterns over time, making Mira more effective than regular ovulation strips. The analyzer can be connected to Mira App to display clear numerical data along with personalized insights on the user's reproductive health.

ABOUT MIRA 

Mira is the first at-home test to offer a personalized and lab-quality tracking system for monitoring women's reproductive health. It uses patented AI algorithms to accurately measure the levels of major hormones in a woman's urine to provide a holistic view of a woman's reproductive health. Mira is FDA-listed, clinically approved, and OB-GYN recommended.

For more information on Mira, please visit miracare.com. 

Press contact: | [email protected] | 

RISE Healthcare Group Logo
Logo for RISE Healthcare Group with white background.

Following the successful launch of a free trial program to bring the Hybrid Assistive Limb (HAL) technology to patients in San Diego, RISE Healthcare Group will be expanding the free trial program for HAL to patients in the Greater Los Angeles, Orange County, and San Diego regions.

Beginning in Q3 of 2022, free trial sessions of HAL will be available to eligible patients at the following RISE Healthcare Group affiliate locations:

RISE Physical Therapy - Encinitas, CA
613 Westlake Street, Suite 130
Encinitas, CA 92024

RISE Physical Therapy - La Mesa, CA
5360 Jackson Drive, Suite 110
La Mesa, CA 91942

SoCal Elite Physical Therapy - Tustin, CA
111 Fashion Lane, Suite 210
Tustin, CA 92780

Tyler Physical Therapy and Pilates
3810 La Crescenta Avenue,
La Crescenta, CA 91214

About HAL
HAL, or Hybrid Assistive Limb, is an FDA-approved wearable medical device developed by Cyberdyne Inc. in Japan that uses neural control to support impaired movement. It is designed to help patients with spinal cord injuries, stroke, and other types of neuromuscular disease achieve greater mobility and independence through personalized treatment sessions using their own nerve signals.

About RISE Healthcare Group
RISE Healthcare Group (RHG) is a dynamic collection of physical therapy practices and outpatient rehabilitation clinics throughout Southern California. Through their partnership with Cyberdyne, they are the first provider in the United States to combine HAL technology with a unique 1-on-1 approach to physical therapy.

Patients with spinal cord injuries, stroke injuries (acquired or traumatic brain injuries), or progressive neuromuscular disorders (Multiple Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Parkinson's Disease, Muscular Dystrophy, etc.) who are interested in participating in a free, cutting-edge HAL trial program are encouraged to reach out via email ([email protected]) or phone (858-755-5200).

More information about HAL and RISE Healthcare Group is also available online at https://www.risehealthcaregroup.com/

Press Contact
Dr. Navid Hannanvash, PT, DPT
CEO, RISE Healthcare Group
[email protected]

Affordable Medication Available to USA Consumers From MedsEngage Online Pharmacy
Affordable Medication Available to USA Consumers From MedsEngage Online Pharmacy

According to news reports, the biopharmaceutical industry is not adequately meeting the demand for consumer access to effective and affordable medicines, which is essential for public health, social equity, and economic development.

In the five years that have passed, it can be presumed that the price disparity has widened. There are savings of about 56% when purchasing medications from a Canadian pharmacy when comparing the global average to American prices. For the USA, MedsEngage provides comparable savings.

Pharmacy prices and formula design help directly bargain pricing with manufacturers and distributors of pharmaceuticals, including speaking on behalf of any pertinent state agency that chooses to take part in the negotiation. MedsEngage provides the power of cheap availability of drugs to every citizen. Generics and biological analog availability also enhance the better pricing for USA consumers when buying from an E-pharma company.

Discounts and Sales offerings at an E-pharmacy are at large. Online medicine purchases also result in financial savings. According to studies, purchasing prescription medications online can result in overall financial savings of up to one-third. Moreover, time savings is one of the E-Pharmacy application's most significant benefits. Customers may simply get medication online and receive prescription medication. Only need to do is use the website to place an order by entering the prescription. There is no need to visit the pharmacy, and there will be no use of standing in lines there. MedsEngage provides the best platform for this practice.

The majority of legitimate retailers who collaborate with E-Pharmacy have a drug checking procedure. These shops ask for a prescription from a private physician, or they offer drug delivery when a patient fills out a questionnaire about their health. Before being disseminated, these surveys are given the doctor's blessing.

A few internet pharmacies provide helpful knowledge on medications and ailments. It offers access to helpful information as well as significant government, university, and medical resources. At MedsEngage, medicines are provided in a way that enables the most affordable prices in the USA with proper description and information.

About the Company:

MedsEngage.com provides the best quality mail order prescriptions to customers. Drugs are sourced from reliable pharmaceutical companies and authorized medicine suppliers, and sold only authentic products of premium quality. None can find a website as safe and secure as MedsEngage that not only helps to order medications quickly but securely too. Easy to navigate the website, and is user-friendly: log in, and don't forget to share prescription for order completion. Medications will be delivered to the doorstep promptly. MedsEngage stick to the utmost safety standards to protect personal information.

For More Information, Connect with MedsEngage at: medsengage.com